DHR vs INTU: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Intuit Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Intuit Inc. · Technology
$279.70
+45.0% upside to fair value
Grade A
High Quality
QuantHub Verdict
INTU has more upside to fair value
(+45.0%).
INTU trades at a lower forward P/E
(16.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
INTU |
| Current Price |
$195.98 |
$279.70 |
| Fair Value Estimate |
$211.54 |
$405.56 |
| Upside to Fair Value |
+7.9%
|
+45.0%
|
| Market Cap |
$138.7B |
$76.5B |
| Forward P/E |
37.8x
|
16.9x
|
| EV / EBITDA |
22.8x
|
11.2x
|
| Price / Sales |
5.6x
|
3.7x
|
| Price / FCF |
26.2x
|
9.9x
|
| Revenue Growth YoY |
+3.7%
|
+10.4%
|
| Gross Margin |
60.7%
|
81.0%
|
| Operating Margin |
21.0%
|
27.5%
|
| Return on Equity |
7.1%
|
23.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
10.08%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Intuit Inc. is a leading technology company specializing in software applications for financial management, including popular products like TurboTax and QuickBooks. The company demonstrates high business quality with a durable competitive moat supported by strong brand recognition, high gross margins of 81%, and a robust return on equity of 23.3%. Despite a moderate revenue growth of 10.4% and ea…
Accumulation Zones
| Metric |
DHR |
INTU |
| Zone Low |
$158.66 |
$304.17 |
| Zone High |
$179.81 |
$344.73 |
| In Buy Zone? |
No
|
Yes
|